Our Company

  1. Home
  2. /
  3. Our Company
Our Company
Bridging and Research Clinic

VVECTOR BIO

VVector Bio, Inc. was founded in 2019 in Montreal, Canada to support R&D and preclinical studies in cell and gene therapy. The aim of the company is helping academic laboratories, hospitals, companies, and other institutions to bring faster to reality their innovative viral vector-based therapies in development. The company provides expert services to help you customize your viral vector carrier and also produce high virus vector yields for preclinical studies

Our production process is well-thought out for easy scalability to a larger-scale production process which facilitates an efficient process transfer to cGMP manufacturing. The company is focused on the production of adeno-associated virus and lentivirus vectors. We have access to the most advanced equipment in the field, and we can support medium scale production up to 20L bioreactor. Confidentiality is something that we take very seriously and the company guarantees 100% secrecy of any project we work on.

 

Our Mission

We strongly believe that the success of virus-vector based therapies greatly depends on the quality and potency of the viral-vector carrier. This is something that can be achieved by proceeding with a well designed, implemented and traceable manufacturing process. Our mission is to make sure our clients receive this service and achieve high-quality vectors that assure the success of their therapies which will translate in the cure of patients.

 

Our Vision

Our vision is to become the leader supplier of viral vectors in Canada and globally by providing a manufacturing process fully automatized that will help to get high yields of viral vectors in a shorter time and reduce the cost of the therapies making them more and more accessible to every patient in need.

 

Our Team

Our team is formed by scientists that together have more than 60 years of experience in designing, optimizing the production, purification, and characterization of different viruses and viral vectors. We are highly skilled and motivated people willing to put our expertise and effort to help the cause of bringing new drugs to reality.

image
Expert Team

TEAM MEMBERS

Alina Venereo Sanchez
Ph.D.

Founder and Chief Executive Officer

Amine Kamen
Ph.D.

Chief Scientific Officer

Omar Farnos Villar
Ph.D.

Operations Director

OUR ADVISORS

Michael M. Avedesian

Business Advisor

VVECTOR BIO, Bridging Research and Clinic